Hepatitis C Virus (HCV) Infection and Neurocognitive Impairment in Subjects with Mild Liver Disease

Marcia Maria Amendola-Pires1,2, Max K Fakoury1,2,3, Hellen Salazar1

  • 1Postgraduate Program in Neurology, Neurobehavioral Laboratory, Department of Neurology, Federal University of the State of Rio de Janeiro, Rio de Janeiro 20270-901, Brazil.

PubMed

Insights

Hepatitis C virus (HCV) infection may cause subtle cognitive issues, even in early stages. Asymptomatic HCV patients showed slower reaction times and attention deficits compared to healthy individuals.

Area of Science:

  • Neuroscience
  • Hepatology
  • Infectious Diseases

Background:

  • Hepatitis C virus (HCV) infection is a major cause of liver disease and mortality.
  • HCV can lead to extrahepatic manifestations, including potential central nervous system effects.
  • Subtle neuropsychological symptoms may occur even in non-cirrhotic, asymptomatic HCV patients.

Purpose of the Study:

  • To investigate cognitive functions in asymptomatic, untreated HCV-infected subjects.
  • To determine if HCV infection is associated with specific neuropsychological deficits.

Main Methods:

  • Twenty-eight asymptomatic HCV patients and 18 healthy controls were assessed.
  • Neuropsychological tests included the Symbol Digit Modalities Test (SDMT), Controlled Oral Word Association Test (COWAT), and Continuous Visual Attention Test (CVAT).
  • Statistical analyses included MANCOVA, ANCOVAS, and discriminant analysis.

Main Results:

  • No significant differences were found in COWAT or SDMT scores between groups.
  • HCV patients exhibited poorer performance in reaction time (RT) and variability of RT (VRT) on the CVAT.
  • Discriminant analysis identified RT as the most reliable variable distinguishing HCV patients from controls (71.7% accuracy).

Conclusions:

  • Asymptomatic HCV infection is associated with deficits in attention, specifically slower reaction times and increased variability.
  • These findings suggest potential impacts on intrinsic alertness and attention stability in HCV patients.
  • Reaction time (RT) serves as a key indicator for cognitive dysfunction in mild HCV disease.

Related Concept Videos

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
163
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
674